• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可乐定在中度高血压患者中急性降低动脉压期间抗利尿激素的渗透调节作用

Osmoregulation of vasopressin during acute lowering of arterial pressure by clonidine in moderate hypertension.

作者信息

Del Bo A, Marabini M, Aghemo A, Zanchetti A

机构信息

Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Italy.

出版信息

J Hypertens Suppl. 1989 Dec;7(6):S200-1. doi: 10.1097/00004872-198900076-00096.

DOI:10.1097/00004872-198900076-00096
PMID:2632717
Abstract

Hypertonic saline (100 mmol in 50 ml) was injected intravenously over 5 min in two groups of moderate essential hypertensive patients (group 1, n = 13; group 2, n = 6). In group 2, arterial pressure had been lowered by infusion of clonidine (0.3 mg in 100 ml saline), from 186 +/- 8/116 +/- 3 to 146 +/- 9/98 +/- 5 mmHg (mean +/- s.e.m.). The hypertonic stimulus increased the plasma osmolality of all subjects from 288 +/- 1 to 296 +/- 1 mosmol/kg (P less than 0.01). Plasma vasopressin increased from baseline values that were not significantly different (P less than 0.01) in each of the two groups. The increase in plasma vasopressin was significantly greater (P less than 0.05) in the group 2 hypertensives with a reduced arterial pressure (+7.81 +/- 1.79 pg/ml) than in the group 1 untreated hypertensives (+3.15 +/- 1.2 pg/ml). In our study, acute lowering of arterial pressure by clonidine did not significantly change baseline vasopressin, but facilitated osmotically induced vasopressin secretion.

摘要

对两组中度原发性高血压患者(第1组,n = 13;第2组,n = 6)在5分钟内静脉注射高渗盐水(50 ml含100 mmol)。在第2组中,通过输注可乐定(100 ml盐水中含0.3 mg),动脉压从186±8/116±3 mmHg降至146±9/98±5 mmHg(均值±标准误)。高渗刺激使所有受试者的血浆渗透压从288±1 mosmol/kg升高至296±1 mosmol/kg(P<0.01)。两组患者血浆血管加压素均从基线值升高(P<0.01),且升高幅度无显著差异。第2组血压降低的高血压患者(升高7.81±1.79 pg/ml)血浆血管加压素升高幅度显著大于第1组未治疗的高血压患者(升高3.15±1.2 pg/ml)(P<0.05)。在我们的研究中,可乐定急性降低动脉压并未显著改变基线血管加压素水平,但促进了渗透压诱导的血管加压素分泌。

相似文献

1
Osmoregulation of vasopressin during acute lowering of arterial pressure by clonidine in moderate hypertension.可乐定在中度高血压患者中急性降低动脉压期间抗利尿激素的渗透调节作用
J Hypertens Suppl. 1989 Dec;7(6):S200-1. doi: 10.1097/00004872-198900076-00096.
2
Vasopresin and human hypertension.血管加压素与人类高血压
Cell Mol Neurobiol. 2003 Oct;23(4-5):617-24. doi: 10.1023/a:1025032431763.
3
Effects of antihypertensive treatment on vasopressin secretion and on its osmoregulation in moderate hypertension.抗高血压治疗对中度高血压患者血管加压素分泌及其渗透调节的影响。
J Hypertens. 1997 Nov;15(11):1277-83. doi: 10.1097/00004872-199715110-00012.
4
Osmoregulation and renal effects of vasopressin in normal and mildly hypertensive subjects.正常和轻度高血压受试者中血管加压素的渗透调节及肾脏效应
Kidney Int. 1984 Feb;25(2):411-5. doi: 10.1038/ki.1984.32.
5
Regulation of vasopressin release in moderately severe essential hypertension.中度严重原发性高血压中血管加压素释放的调节
Clin Auton Res. 1991 Jun;1(2):109-14. doi: 10.1007/BF01826205.
6
Mechanism of suppression of vasopressin and adrenocorticotropic hormone secretion by clonidine in anesthetized dogs.
J Pharmacol Exp Ther. 1984 Apr;229(1):1-8.
7
Haemodynamics and fluid balance after intravenous infusion of 1.5% glycine in sheep.绵羊静脉输注1.5%甘氨酸后的血流动力学和液体平衡
Acta Anaesthesiol Scand. 1993 Apr;37(3):281-7. doi: 10.1111/j.1399-6576.1993.tb03716.x.
8
Osmoregulation of thirst and vasopressin during normal menstrual cycle.正常月经周期中口渴和血管加压素的渗透调节
Am J Physiol. 1988 Apr;254(4 Pt 2):R641-7. doi: 10.1152/ajpregu.1988.254.4.R641.
9
Osmoregulation and baroregulation of plasma vasopressin in essential hypertension.原发性高血压患者血浆血管加压素的渗透调节和压力调节
J Cardiovasc Pharmacol. 1986;8 Suppl 7:S87-91. doi: 10.1097/00005344-198600087-00017.
10
Clonidine can lower blood pressure by inhibiting vasopressin release.
Eur J Pharmacol. 1985 Feb 12;109(1):111-6. doi: 10.1016/0014-2999(85)90546-1.